XTL BIOPHARMACEUTICALS LTD.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $1.3M | $8.6M | $3.3M |
| FY2019 | $697.0K | $8.6M | $3.3M |
| FY2020 | $2.9M | $6.5M | $3.6M |
| FY2021 | $1.3M | $6.6M | $3.0M |
| FY2022 | $187.0K | $4.2M | $2.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $1.3M | $8.6M | $3.3M |
| FY2019 | $697.0K | $8.6M | $3.3M |
| FY2020 | $2.9M | $6.5M | $3.6M |
| FY2021 | $1.3M | $6.6M | $3.0M |
| FY2022 | $187.0K | $4.2M | $2.1M |